2,6-Dichloroquinoxaline is a chlorinated heterocyclic compound used as a pharmaceutical intermediate. Its structure consists of a quinoxaline ring with chlorine substituents at the 2 and 6 positions, which contributes to its utility in organic synthesis and drug manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 18671-97-1
(3beta)-16-[(3beta)-3-(Acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol 3-Acetate
pharmaceutical intermediate
Ambroxol EP Impurity B
pharmaceutical intermediate
Carbamic acid, N-[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]-, ethyl ester
pharmaceutical intermediate
2-Cyanobenzeneacetic acid
pharmaceutical intermediate
2,3,6-Trichloroquinoxaline
research compound
1-(3-Methylquinoxalin-2-yl)ethan-1-one
research compound
2,3-Dichloroquinoxaline
pharmaceutical intermediate
5-Quinoxalinamine, 6-methoxy-2,3-dimethyl-
pharmaceutical intermediate
2,6-dichloroquinoxaline
WFOKVKYNVKVWFK-UHFFFAOYSA-N
C1=CC2=NC(=CN=C2C=C1Cl)Cl